← FDA DRUG APPROVALS

FDA ANDA · ANDA077840

ONDANSETRON HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA077840
TYPE
ANDA
ORIGINAL APPROVAL
2007-01-19
LATEST ACTION
2016-05-12
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ONDANSETRON HYDROCHLORIDEDiscontinued
ONDANSETRON HYDROCHLORIDE EQ 2MG BASE/ML · INJECTABLE · INJECTION

Approval history

2016-05-12Labeling · Supplement 6 · standardAP
2014-12-08Labeling · Supplement 4 · standardAP
2014-12-08Labeling · Supplement 5 · standardAP
2013-01-11Labeling · Supplement 2 · standardAP
2007-01-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →